Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice

Experimental Hematology

Volumn 27, Issue 11, 1999, Pages 1609-1620

  Ailles, Laurie E ^a,b   Humphries, R Keith ^a,b   Thomas, Terry E ^a   Hogge, Donna E ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

AML; Gene transfer; Immunodeficient mice; Longterm culture; Progenitor; Retrovirus; Transduction

Indexed keywords

INTERLEUKIN 3; STEEL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ANIMAL CELL; ARTICLE; BIOASSAY; CELL CULTURE; CELL GROWTH; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SOUTHERN BLOTTING; STEM CELL;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0032700495     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00099-5     Document Type: Article

References (61)

1. Sutherland H.J., Lansdorp P.M., Henkelman D.H., Eaves A.C., Eaves C.J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A. 87:1990;3584.
2. Bhatia M., Wang J.C.Y., Kapp U., Bonnet D., Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 94:1997;5320.
3. -) human hematopoietic cells. novel responses to flt3-ligand and thrombopoietin J Exp Med. 183:1996;2551.
4. Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A. 94:1997;9836.
5. Ailles L.E., Gerhard B., Hogge D.E. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood. 90:1997;2555.
6. Shultz L.D., Schweitzer P.A., Christianson S.W., Gott B., Schweitzer I.B., Tennent B., McKenna S., Mobraaten L., Rajan T.V., Greiner D.L., Leiter E.H. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 154:1995;180.
7. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 3:1997;730.
8. Ailles L.E., Gerhard B., Kawagoe H., Hogge D.E. Growth characteristics of acute myelogenous leukemia progenitors which initiate malignant hematopoiesis in NOD/SCID mice. Blood. 94:1999;1761.
9. -. Blood. 92:1998;4325.
10. Larochelle A., Vormoor J., Hanenberg H., Wang J.C.Y., Bhatia M., Lapidot T., Moritz T., Murdoch B., Xiao X.L., Kato I., Williams D.A., Dick J.E. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow. implications for gene therapy Nat Med. 2:1996;1329.
11. + subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A. 91:1994;12223.
12. Lemischka I.R., Raulet D.H., Mulligan R.C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell. 45:1986;917.
13. Williams D.A., Lemischka I.R., Nathan D.G., Mulligan R.C. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature. 310:1984;476.
14. Szilvassy S.J., Fraser C.C., Eaves C.J., Lansdorp P.M., Eaves A.C., Humphries R.K. Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc Natl Acad Sci U S A. 86:1989;8798.
15. Drize N., Chertkov J., Sadovnikova E., Tiessen S., Zander A. Long-term maintenance of hematopoiesis in irradiated mice by retrovirally transduced peripheral blood stem cells. Blood. 89:1997;1811.
16. Conneally E., Eaves C.J., Humphries R.K. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood. 91:1998;3487.
17. Nolta J.A., Smogorzewska E.M., Kohn D.B. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood. 86:1995;101.
18. - immunodeficient patients. Science. 270:1995;470.
19. Hanania E.G., Giles R.E., Kavanagh J., Ellerson D., Zu Z., Wang T., Su Y., Kudelka A., Rahman Z., Holmes F., Hortobagyi G., Claxton D., Bachier C., Thall P., Cheng S., Hester J., Ostrove J.M., Bird R.E., Chang A., Korbling M., Seong D., Cote R., Holzmayer T., Mechetner E., Heimfeld S., Berenson R., Burtness B., Edwards C., Bast R., Andreeff M., Champlin R., Deisseroth A.B. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci U S A. 93:1996;15346.
20. Dunbar C.E., Cottler-Fox M., O'Shaughnessy J.A., Doren S., Carter C., Berenson R., Brown S., Moen R.C., Greenblatt J., Stewart F.M., Leitman S.F., Wilson W.H., Cowan K., Young N.S., Nienhuis A.W. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 85:1995;3048.
21. Dunbar C.E., Seidel N.E., Doren S., Sellers S., Cline A.P., Metzger M.E., Agricola B.A., Donahue R.E., Bodine D.M. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A. 93:1996;11871.
22. Smith L.J., Benchimol S. Introduction of new genetic material into human myeloid leukemic blast stem cells by retroviral infection. Mol Cell Biol. 8:1988;974.
23. Brenner M.K., Rill D.R., Moen R.C., Krance R.A., Mirro Jr J., Anderson W.F., Ihle J.N. Gene-marking to trace origin of relapse after autologous bone- marrow transplantation. Lancet. 341:1993;85.
24. Kawagoe H., Humphries R.K., Blair A., Sutherland H.J., Hogge D.E. Expression of Hox genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 13:1999;687.
25. Hawley R.G., Lieu F.H.L., Fong A.Z.C., Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:1994;136.
26. Conneally E., Bardy P., Eaves C.J., Thomas T., Chappel S., Shpall E.J., Humphries R.K. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood. 87:1996;456.
27. Kay R., Takei F., Humphries R.K. Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens. J Immunol. 145:1990;1952.
28. Markowitz D., Goff S., Bank A. Construction and use of a safe and efficient amphotrophic packaging cell line. Virology. 167:1988;400.
29. Cone R.D., Mulligan R.C. High-efficiency gene transfer into mammalian cells. generation of helper-free recombinant retrovirus with broad mammalian host range Proc Natl Acad Sci U S A. 81:1984;6349.
30. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukaemia cells with long-term proliferative ability in vitro and in vivo. Blood. 89:1997;3104.
31. Mager D.L., Freeman J.D. Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses. J Virol. 61:1987;4060.
32. Avanzi G.C., Lista P., Giovinazzo B., Miniero R., Saglio G., Benetton G., Coda R., Cattoretti G., Pegoraro L. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol. 69:1988;359.
33. Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo- derived stem cells. Cell. 51:1987;503.
34. Hughes P.F.D., Eaves C.J., Hogge D.E., Humphries R.K. High-efficiency gene transfer to human hematopoietic cells maintained in long-term marrow culture. Blood. 74:1989;1915.
35. Fischer M., Goldschmitt J., Peschel C., Brakenhoff J.P.G., Kallen K.J., Wollmer A., Grötzinger J., Rose-John S. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol. 15:1997;142.
36. Sutherland H.J., Hogge D.E., Cook D., Eaves C.J. Alternative mechanisms with and without Steel factor support primitive human hematopoiesis. Blood. 81:1993;1465.
37. - bone marrow cells with multilineage potential at the single-cell level. key role of thrombopoietin Blood. 90:1997;2282.
38. Haylock D.N., Horsfall M.J., Dowse T.L., Ramshaw H.S., Niutta S., Protopsaltis S., Peng L., Burrell C., Rappold I., Buhring H.-J., Simmons P.J. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood. 90:1997;2260.
39. -) human bone marrow progenitor cells. J Immunol. 158:1997;5169.
40. Young J.C., Varma A., DiGiusto D., Backer M.P. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood. 87:1996;545.
41. Kühr T., Dougherty G.J., Klingemann H.-G. Transfer of the tumor necrosis factor |a| gene into hematopoietic progenitor cells as a model for site-specific cytokine delivery after marrow transplantation. Blood. 84:1994;2966.
42. Dilloo D., Bacon K., Holden W., Zhong W., Burdach S., Zlotnik A., Brenner M. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat Med. 2:1996;1090.
43. Lieu F.H.L., Hawley T.S., Fong A.Z.C., Hawley R.G. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene. implications for immune gene therapy Cancer Gene Ther. 4:1997;167.
44. Hughes P.F.D., Thacker J.D., Hogge D., Sutherland H.J., Thomas T.E., Lansdorp P.M., Eaves C.J., Humphries R.K. Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. J Clin Invest. 89:1992;1817.
45. Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 10:1990;4239.
46. Guan Y., Hogge D. Characterization of the proliferative status of malignant progenitors from patients with acute myelogenous leukemia (AML). Exp Hematol. 26:1998;810. (abstr).
47. Ponchio L., Conneally E., Eaves C. Quantitation of the quiescent fraction of long-term culture-initiating cells (LTC-IC) in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. Blood. 86:1995;3314.
48. Lasky L.C., Fox S.B., Smith J., Bostrom B. Collection and use of peripheral blood stem cell in very small children. Bone Marrow Transplant. 7:1991;281.
49. Gan O.I., Murdoch B., Larochelle A., Dick J.E. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 90:1997;641.
50. Zandstra P.W., Conneally E., Petzer A.L., Piret J.M., Eaves C.J. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A. 94:1997;4698.
51. Conneally E., Zandstra P., Rose-John S., Piret J., Eaves C.J. Expansion of human cord blood progenitors with a IL-6/sIL-6R fusion protein. Exp Hematol. 26:1998;699. (abstr).
52. Petzer A.L., Eaves C.J., Barnett M.J., Eaves A.C. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood. 90:1997;64.
53. Lisovsky M., Estrov Z., Zhang X., Consoli U., Sanchez-Williams G., Snell V., Munker R., Goodacre A., Savchenko V., Andreeff M. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells. regulation of Bcl-2 and Bax Blood. 88:1996;3987.
54. Piacibello W., Fubini L., Sanavio F., Brizzi M.F., Severino A., Garetto L., Stacchini A., Pegoraro L., Aglietta M. Effects of human FLT3 ligand on myeloid leukemia cell growth. heterogeneity in response and synergy with other hematopoietic growth factors Blood. 86:1995;4105.
55. Drexler H.G., Quentmeier H. Thrombopoietin. expression of its receptor MPL and proliferative effects on leukemic cells Leukemia. 10:1996;1405.
56. Carlesso N., Pregno P., Bresso P., Gallo E., Pileri A., Zsebo K.M., Ferrero D. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia. 6:1992;642.
57. Vellenga E., Ostapovicz D., O'Rourke B., Griffin J.D. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia. 1:1987;584.
58. Yonemura Y., Ku H., Hirayama F., Souza L.M., Ogawa M. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci U S A. 93:1996;4040.
59. low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum Gene Ther. 9:1998;1497.
60. Cheng L., Du C., Lavau C., Chen S., Tong J., Chen B.P., Scollay R., Hawley R.G., Hill B. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood. 92:1998;83.
61. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 283:1999;682.